Insulin-Like Growth Factor (IGF)-I Gene Deletion

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Reviews in Endocrine & Metabolic Disorders

• Publication date

  2002-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1023/A:1020957809082PMID 12424437
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin-Like Growth Factor -I Deficiency

  2004cited by this paper
• Growth Hormone Insensitivity: Pathophysiology, Diagnosis, Clinical Variation and Future Perspectives

  2001cited by this paper
• Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion.

  2000cited by this paper
• Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice.

  1999cited by this paper
• Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.

  1999cited by this paper
• Long-Term Treatment of Growth Hormone Insensitivity Syndrome with IGF-I

  1999cited by this paper
• Printed in U.S.A. Copyright © 1999 by The Endocrine Society Insulin-Like Growth Factor I Is Essential for Postnatal Growth in Response to Growth Hormone

  1999cited by this paper
• The insulin‐like growth factor‐I (IGF‐I) gene in individuals born small for gestational age (SGA)

  1999cited by this paper
• Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice.

  1998cited by this paper
• Phenotype: genotype relationships in growth hormone insensitivity syndrome.

  1997cited by this paper
• Is growth hormone deficiency a viable diagnosis?

  1997cited by this paper
• Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.

  1997cited by this paper
• Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene.

  1996cited by this paper
• Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome--a clinical research center study. GHIS Collaborative Group.

  1996cited by this paper
• Insulin-like growth factors and their binding proteins: biological actions.

  1995cited by this paper
• Laron syndrome: clinical features, molecular pathology and treatment.

  1994cited by this paper
• IGF-I is required for normal embryonic growth in mice.

  1993cited by this paper
• Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome).

  1993cited by this paper
• Role of insulin-like growth factors in embryonic and postnatal growth.

  1993cited by this paper
• The effect of recombinant human insulin‐like growth factor‐I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome)

  1993cited by this paper
• Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r).

  1993cited by this paper
• Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism).

  1991cited by this paper
• Low prevalence of insulin-like growth factor-I gene mutations in human growth disorders.

  1990cited by this paper
• Insulin-Like Growth Factor-I Gene Analysis in Subjects with Constitutionally Variant Stature

  1990cited by this paper
• The modified minimal model: application to measurement of insulin sensitivity in children.

  1990cited by this paper
• Insulin-like growth factors and their binding proteins.

  1990cited by this paper
• Insulin-like growth factors and their binding proteins.

  1990cited by this paper
• Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism.

  1989cited by this paper
• Organization and sequence of the human insulin-like growth factor I gene. Alternative RNA processing produces two insulin-like growth factor I precursor peptides.

  1986cited by this paper
• The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin.

  1978cited by this paper
• Genetic pituitary dwarfism with high serum concentation of growth hormone--a new inborn error of metabolism?

  1966cited by this paper

• Maternal and Fetal Therapy: Can We Optimize Fetal Growth?

  2019cites this paper
• Prophylaxis and treatment of foetal growth restriction.

  2018cites this paper
• Review of Insulin-Like Growth Factor 1 Signaling Pathway and Its Role in Protection against Brain Diseases

  2017cites this paper
• Placenta-directed gene therapy for fetal growth restriction.

  2017cites this paper
• Short children born small for gestational age outcomes in the era of growth hormone therapy.

  2017cites this paper
• Skeletal effects of growth hormone and insulin-like growth factor-I therapy.

  2016cites this paper
• Neurotrophic uncoupling of IGF-1 in Alzheimer’s disease: translation into early diagnosis and involvement of lifestyle risk factors

  2015cites this paper
• Mechanisms of action of brain insulin against neurodegenerative diseases

  2014cites this paper
• IGF-I and NEFA concentrations in fetal fluids of term pregnancy dogs.

  2014cites this paper
• Exploring the phenotypes of individuals with midline brain defects

  2014cites this paper
• Deterioration of trabecular bone microarchitecture in the lumbar vertebrae in growing male mice following sciatic neurectomy

  2014cites this paper
• Internalisation cellulaire et activité biologique de PNA bloqueurs stériques de la traduction, conjugués au peptide (R/W)9

  2014cites this paper
• Deterioration of trabecular bone microarchitecture in the lumbar vertebrae in growing male mice following sciatic neurectomy

  2014cites this paper
• Receptor Cross-Talk in the Biology & Therapeutics Of Pediatric Rhabdoid Brain Tumors

  2014cites this paper
• Bioinformatic Analysis of Benzo-α-Pyrene-Induced Damage to the Human Placental Insulin-Like Growth Factor-1 Gene

  2013cites this paper
• Insulin-like growth factor 1 and 2 (IGF1, IGF2) expression in human microglia: differential regulation by inflammatory mediators

  2013cites this paper
• The many faces of insulin-like peptide signalling in the brain

  2012cites this paper
• Insulin-Like Growth Factor-I Deficiency in Children with Growth Hormone Insensitivity

  2012cites this paper
• Role of Insulin-like Growth Factor-1 in the Regulation of Skeletal Growth

  2012cites this paper
• Insulin like growth factor-I: a critical mediator of the skeletal response to parathyroid hormone.

  2012cites this paper
• Insulin-like growth factor-I and bone

  2011cites this paper
• The IGF system

  2011cites this paper
• Foetal programming of brain function and behaviour : A behavioural and molecular characterisation of a murine placental imprinted gene deletion model

  2010cites this paper
• The Effect of Glucagon-like Peptide-2 on Insulin-like Growth Factor-1 in Murine Intestinal Subepithelial Myofibroblasts

  2010cites this paper
• Maternal-placental insulin-like growth factor (IGF) signaling and its importance to normal embryo-fetal development.

  2010cites this paper
• Relationships Between Osteoprotegerin (OPG), Receptor Activator of Nuclear Factor κΒ Ligand (RANKL), and Growth Hormone (GH) Secretory Status in Short Children

  2009cites this paper
• Levels of insulin-like growth factors and their receptors in placenta in relation to macrosomia.

  2009cites this paper
• Growth in the first two years of life.

  2008cites this paper
• Being Born Large for Gestational Age : Metabolic and Epidemiological Studies

  2008cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 363 Being Born Large for Gestational Age Metabolic and Epidemiological Studies

  2008cites this paper
• Therapeutic aspects of growth hormone and insulin‐like growth factor‐I treatment on visceral fat and insulin sensitivity in adults

  2007cites this paper
• Hormones and body size evolution in papionin primates.

  2007cites this paper
• Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults.

  2006cites this paper
• Mechanisms of osteoporosis in spinal cord injury

  2006cites this paper
• Hormonal Regulation of Male Reproductive Tract Development

  2005cites this paper
• Role of insulin-like growth factors in neuronal plasticity and neuroprotection.

  2005cites this paper
• IGF-I Deficiency: Lessons from Human Mutations

  2005cites this paper
• The role of the insulin-like growth factor system in prenatal growth.

  2005cites this paper
• Role of insulin-like growth factors in neuronal plasticity and neuroprotection.

  2005cites this paper
• Lymphangiogenesis and lymphatic metastasis

  2005cites this paper
• Genetic control of growth.

  2005cites this paper
• Trophic effects of insulin-like growth factor-I (IGF-I) in the inner ear.

  2004cites this paper
• Insulin-Like Growth Factors and Their Binding Proteins in Children Born Small for Gestational Age: Implication for Growth Hormone Therapy

  2003cites this paper